HIV

HIV

Human immunodeficiency virus (HIV) is a type of retrovirus, that if left untreated can lead to AIDs (Acquired ImmunoDeficiency Syndrome.

Human immunodeficiency virus (HIV) is a type of retrovirus, that if left untreated can lead to AIDs (acquired immunodeficiency syndrome).

Timeline

September 11, 2019

CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia

Researchers based in China used CRISPR to edit hematopoietic stem and progenitor cells (HSPCs) to make the gene CCR5 non-functional, which makes cells resistant to HIV-1. The CRISPR-edited CCR5-ablated HSPCs were transplanted into a patient with HIV-1 infection and acute lymphoblastic leukemia, which was in remission. Although there was long-term engraftment of the edited HSPCs, only about 5% of lymphocytes contained the CCR5 disruption.

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Jordan Salama
May 31, 2020
Scientific American Blog Network
Health care workers at the city hospital hit hardest by the pandemic go beyond their job description in tending to a vulnerable population
May 28, 2020
@TIMESNOW
Even after a COVID-19 vaccine is developed and deployed, the coronavirus will likely remain for years to come, and may eventually, become endemic like HIV, measles and chickenpox, says a report.
May 26, 2020
BioSpace
IAVI and Merck Collaborate to Develop Vaccine Against SARS-CoV-2 - read this article along with other careers information, tips and advice on BioSpace
Chelsea Weidman Burke
May 21, 2020
BioSpace
To learn more about ImmunityBio's HIV drug candidate, BioSpace spoke to Dr. Whitney and Jeffrey Safrit, PhD, director of Cell-Mediated Therapies in Virology at NantKwest.
Alex Keown
May 18, 2020
BioSpace
The results set up the potential for regulatory approval.
BioSpace
May 18, 2020
BioSpace
Interim analysis from HPTN 083 study shows investigational, long-acting injectable cabotegravir (CAB LA) administered every two months is 69% more effective than daily pills in preventing HIV acquisition
Michael Segalov
May 13, 2020
the Guardian
Covid-19%20crisis%20raises%20hopes%20of%20end%20to%20UK%20transmission%20of%20HIV%20%7C%20Aids%20and%20HIV%20%7C%20The%20Guardian
May 3, 2020
Livemint
'The public's hopes are repeatedly raised and then dashed, as various proposed solutions fall before the final hurdle,' says a CNN report.From a total of 102 candidate vaccines for coronavirus in the race, eight leading vaccines are in human testing phase
May 1, 2020
clinicaltrials.gov
COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings - Full Text View.
Sarah Boseley
May 1, 2020
the Guardian
A community health volunteer conducts a malaria test in a village in Myanmar. Photograph: Ye Aung Thu/AFP via Getty Images
Adam Rogers
April 24, 2020
Wired
Scientists have no shortage of contenders to fight the new coronavirus. But to find the winners, they're trying new approaches to testing.
April 24, 2020
clinicaltrials.gov
Clinical Characterisation Protocol for COVID-19 in People Living With HIV - Full Text View.
April 22, 2020
clinicaltrials.gov
Impact of Long-term Protease Inhibitors in Patients Living With HIV on the Incidence of COVID-19 ( COVIP ) - Full Text View.
April 21, 2020
clinicaltrials.gov
Coronavirus Outcomes Registries in Immunocompromised Individuals Australia (CORIA) - Full Text View.
Walt Bonner
April 20, 2020
Fox News
Before coronavirus, other deadly pandemics and epidemics ravaged the globe.
April 3, 2020
clinicaltrials.gov
COVID-19 in Patients With HIV - Full Text View.
April 14, 2020
clinicaltrials.gov
Pyridostigmine in Severe SARS-CoV-2 Infection - Full Text View.
Tanya Lewis
April 16, 2020
Scientific American
Scientific American is the essential guide to the most awe-inspiring advances in science and technology, explaining how they change our understanding of the world and shape our lives.
Richard Horton
April 9, 2020
the Guardian
Illustration: Thomas Pullin
SHOW MORE

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.